Aurora Cannabis Inc (ACB)

[leopard messiah]

Impairment value, meh. Doesn’t affect sales or profit, the real SP drivers.

The issue with smaller producers, Apha, Tilray, Cronos, is they don’t produce or sell much cannabis. Apha had great revenue, but 77 percent of it was from a pharmaceutical sales company they acquired. That’s why they couldn’t maintain the nice pop from the news. Market knows their growth is limited.

The cannabis companies that appreciate in value will come from companies who produce and sell the most cannabis.

We’ll see what the smaller producers do in the coming quarters.